Document is current
Any future updates will be listed below
-
Authors
Apps, John R. http://orcid.org/0000-0001-7902-482X
Gonzalez-Meljem, Jose Mario
Guiho, Romain
Pickles, Jessica C.
Prince, Eric
Schwalbe, Edward
Joshi, Nikhil
Stone, Thomas J.
Ogunbiyi, Olumide
Chalker, Jane
Bassey, Akang
Otto, Georg
Davies, Rosalind
Hughes, Debbie
Brandner, Sebastian
Tan, Enrica
Lee, Victoria
Hayhurst, Caroline
Kline, Cassie
Castellano, Sergi
Hankinson, Todd
Deutschbein, Timo
Jacques, Thomas S.
Martinez-Barbera, Juan Pedro
-
Funding
Funding for this research was provided by:
CHILDREN with CANCER UK (15-190)
Cancer Research UK (C54322/A27727)
Children's Cancer and Leukaemia Group (2017-05)
Brain Tumour Charity (GN-000382, GN-000522)
- License Information
-
More Information
Article History
Received: 3 June 2024
Accepted: 17 July 2024
First Online: 10 August 2024
Declarations
:
: All work was within ethical approval REC14/LO/2265, REC19/SC/0217 and REC21/L0/0707 with appropriate consent where required and performed in accordance with the Declaration of Helsinki.
: Cassie Kline receives clinical trial support and drug supply from Bristol-Myers Squibb Co and Day One Biotherapeutics for the PNOC029 study (NCT05465174). In addition, she has other contracts relevant to other clinical trials not pertinent to this publication, specifically Curis Inc, Regeneron Pharmaceuticals, Midatech, Ipsen, Chimerix and Kazia.
